Two Private Equity Firms Want Amil. The Gap Is US$385 Million and the Hospitals Are Getting Nervous
Brazil · BUSINESS Key Facts —Who is buying Advent International and Bain Capital. Not UnitedHealth — the American group owned Amil, sold it in 2023, and is not in this process. —The gap Roughly R$2 billion, about US$385 million. The seller is asking around R$18 billion, about US$3.5 billion; the buyers are reported at R$14–17 […] The post Two Private Equity Firms Want Amil. The Gap Is US$385…
Two private equity firms, Advent International and Bain Capital, are in advanced talks to acquire Amil, Brazil's third-largest health insurer. The controlling shareholder, José Seripieri Filho, wants around R$18 billion (about US$3.5 billion) for the insurer, while the buyers are reportedly willing to pay between R$14 and R$17 billion (roughly US$2.7 to US$3.3 billion).
The gap between the two sides is about R$2 billion or US$385 million. Due diligence has been completed, and no deal has been signed yet. The stalled sale is causing hospitals to postpone agreements and hold other dealings in suspense while waiting to see who ends up in control. This creates pressure for a resolution on almost any terms, which typically favors the buyer.
Proposed changes to Brazil's supplementary health rules could also complicate or delay the transaction. If a deal is reached near the lower end of the range, it could mark the industry down; if it's near the top, it could mark it up. The outcome of the Amil sale sets a reference price for the entire sector, and the hospitals, smaller insurers, and listed operators are all watching the outcome closely.
Written by urgent.news from The Rio Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
